Daewoong's Urusa Records Over 36 Billion Won of Sales

Published: 2005-03-11 06:57:00

Updated: 2005-03-11 06:57:00

Daewoong Pharmaceutical recently announced that its popular over-the-counter (OTC) medication Urusa (active ingredient: ursodeoxycholic acid) surpassed over 36 billion won of sales revenue last year, making it as the nation's leading OTC medication in the fatigue relief category.

The company official stated that the sales of Urusa last year yielded an explosive annual growth of 61%, and its ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.